Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction

Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction

Aim. To assess the effectiveness of ivabradine therapy in heart rate (HR) reduction among patients with acute heart failure (AHF). Material and methods. ОIn total, 40 dopamine-treated patients with inferior myocardial infarction (MI) were examined. All participants were randomised into Groups A (n=2...

Full description

Bibliographic Details
Main Authors:	S. A. Sayganov, Yu. N. Grishkin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	острая сердечная недостаточность инфаркт миокарда ивабрадин синусовая тахикардия
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2085

Similar Items

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
by: A. I. Chesnikova, et al.
Published: (2008-06-01)

Positive effect of if-channel’s blocker ivabradine therapy in a patient with ischemic chronic heart failure with preserved left ventricle ejection fraction and hereditary thrombophilia (clinical case)
by: Iurii N. Belenkov, et al.
Published: (2019-09-01)

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
by: V. I. Podzolkov, et al.
Published: (2023-01-01)

ACUTE MYOCARDIAL INFARCTION SPECIFICS IN PATIENTS WITH CHRONIC TONSILLITIS
by: Kh. R. Dzhukaeva, et al.
Published: (2014-02-01)

PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE
by: Yu. M. Lopatin, et al.
Published: (2015-08-01)

Development of Right Ventricular Dysfunction in Acute Myocardial Infarction and Chronic Heart Failure
by: L. I. Sergeyeva, et al.
Published: (2007-04-01)

Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19
by: V. I. Podzolkov, et al.
Published: (2022-08-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

The role of the cardiac lymphatic system in the development and progression of heart failure and novel therapeutic approaches for its management in post-infarction cardiac remodeling
by: Yu. S. Korneva, et al.
Published: (2020-07-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)

Comparing effectiveness of tissue and plasma plasminogen activator thrombolysis in patients with various severity of acute myocardial infarction
by: V. A. Shulman, et al.
Published: (2005-12-01)

Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III
by: S. G. Kanorskiy, et al.
Published: (2011-04-01)

N-terminal propeptide of type III procollagen for predicting diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-02-01)

Prognostic value of short-term trajectories of left ventricular ejection fraction in patients with first myocardial infarction and percutaneous coronary intervention
by: T. M. Timofeeva, et al.
Published: (2023-01-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

Cytochrome P-450 3A4 system in patients with acute myocardial infarction
by: A. G. Vladimirov, et al.
Published: (2008-08-01)

ОСТРАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ. ЕВРОПЕЙСКИЙ КОНСЕНСУС: ПЕРЕВОД РЕКОМЕНДАЦИЙ
by: Н. Т. Ватутин, et al.
Published: (2015-08-01)

Perioperative Myocardial Damage and Heart Failure in Noncardiac Surgery. Part 1. Etiopathogenesis and Prognosis of Perioperative Cardiac Complications (Review)
by: I. A. Kozlov, et al.
Published: (2019-04-01)

Радиочастотная аблация высокой мощности при лечении желудочковых тахикардий у пациентов со структурной патологией сердца: результаты одного года наблюдения многоцентрового проспективного регистра
by: S.V. Korolev, et al.
Published: (2023-06-01)

CLINICAL AND FUNCTIONAL CHARACTERISTICS OF PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION DEPENDING ON THE METABOLIC SYNDROME PRESENCE OR ABSENCE
by: R. D. Kurbanov, et al.
Published: (2015-09-01)

LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

Pleiotropic effects of levosimendan on the heart and other organs
by: V. V. Lomivorotov, et al.
Published: (2017-07-01)

ACUTE RIGHT VENTRICULAR FAILURE
by: A. E. Bautin, et al.
Published: (2018-11-01)

The role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling
by: A. P. Khlapov, et al.
Published: (2008-09-01)

Prognostic value of renal function in patients with acute decompensation of chronic heart failure
by: I. A. Meray, et al.
Published: (2008-08-01)

Pharmacological therapy of acute heart failure: what is available now and what is expected in future
by: A. A. Eremenko
Published: (2020-05-01)

THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

Современные и потенциальные возможности применения левосимендана в лечении сердечной недостаточности и септического шока: обзор литературы
by: Vladimir A. Boboshko, et al.
Published: (2023-07-01)

ВЛИЯНИЕ МЕТАБОЛИЧЕСКОЙ ХИРУРГИИ НА ТЕЧЕНИЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ
by: Олег Викторович Корнюшин, et al.
Published: (2022-01-01)

ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS
by: R. Bhattarai, et al.
Published: (2015-09-01)

CARDIOSYNCHRONOUS ELECTROMYOSTIMULATION IN PATIENTS WITH ACUTE HEART FAILURE
by: G. G. Ivanov, et al.
Published: (2013-12-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention
by: K. A. Nazarova, et al.
Published: (1970-01-01)

Intravenous nitrates in modern cardiology
by: I. V. Zhirov, et al.
Published: (2005-12-01)

Use of Modified Glucose-Insulin-Potassium Mixture in Cardiosurgical Patients
by: V. N. Poptsov, et al.
Published: (2006-12-01)

SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVAL
by: I. V. Zhirov, et al.
Published: (2015-09-01)

Acute nitroglycerin test for predicting perindopril therapy effectiveness in patients with coronary heart disease and chronic heart failure
by: I. G. Fomina, et al.
Published: (2005-12-01)